Purchase Order 36C26220P0694
- Not listed
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price purchase order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide histology and cytology reagents. The $290,857.89 contract, which did not utilize a set-aside, has a completion date of November 29, 2019. Abbott Molecular is a manufacturer of medical diagnostic products and has a history of supplying a range of molecular diagnostics equipment, reagents, and testing services...
- This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the U.S. Department of Veterans Affairs (VA) to provide laboratory reagents. The contract has a ceiling value of $237,608.36 and is a delivery order under the VA's Invitro Diagnostics, Reagents, Test (FSS-65-VII) Federal Supply Schedule contract. The contract is for a firm fixed price and does not have a set-aside designation. Abbott Molecular is the prime contractor and there is no information...
- The U.S. Department of Veterans Affairs (VA) has awarded a $159,750.00 firm-fixed-price purchase order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide Alinity M analyzer equipment. This contract has a period of performance through February 12, 2028 and is not designated as a set-aside contract. Abbott Molecular is a healthcare company that develops diagnostic products and services, including molecular diagnostics equipment, reagents, and testing services for federal...
- This federal contract award to Abbott Molecular Inc. is for the provision of oncology and HIV-1 genotype reagents to the Department of Veterans Affairs (VA). The $269,478.53 firm fixed-price Blanket Purchase Agreement (BPA) Call contract has a period of performance through November 8, 2017. Abbott Molecular, a subsidiary of Abbott Laboratories, has provided a range of molecular diagnostics equipment, reagents, and testing services to federal agencies including the VA. The contract does not...
- This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 4. The $92,726.03 Firm Fixed Price Delivery Order is for laboratory tests and was awarded on April 7, 2019 with a completion date of January 6, 2021. The contract was awarded under the GSA Schedule for Critical Analyzers, Laboratory (FSS-66-III) and did not utilize a set-aside. Abbott Molecular is a manufacturer of...
- This is a federal contract award by the Department of Veterans Affairs (VA) Veterans Health Administration to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the provision of molecular reagents. The contract is a Delivery Order under the GSA Schedule 65-VII for In-Vitro Diagnostics, Reagents, and Test Kits, with a Firm Fixed Price of $149,947.60. The contract is not set-aside and has a completion date of October 13, 2018. Abbott Molecular is a manufacturer of diagnostic...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $305,500 firm fixed price purchase order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide COVID-19 diagnostic products and services. The award was not set aside for any specific business type. Abbott Molecular is a manufacturer of medical diagnostic equipment, reagents, and tests, and has provided similar products and services to the VA, Centers for Disease Control and Prevention, and...
- This is a delivery order award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for cost per reportable result services at the VA Puget Sound Health Care System. The $12,017,229.54 firm-fixed-price contract has a period of performance through November 30, 2025 and was issued under the GSA Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). The award was made by the Department of Veterans Affairs (VA) without a set-aside designation. Abbott Molecular provides a...
- This is a delivery order issued under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule contract to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The $169,843.85 fixed-price award was made by the Department of Veterans Affairs Veterans Health Administration to provide "Cost Per Test Testing (Emergency)" services. The order does not have a set-aside designation. Abbott Molecular is a leading provider of molecular diagnostics products and services to federal...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, a global healthcare company. The contract has an award value of $507,223.63 and is an Indefinite Delivery/Indefinite Quantity (IDIQ) contract for the procurement of Alinity reagents and supplies. The contract has a performance period through September 30, 2024 and utilizes a Firm Fixed Price pricing structure. This contract is not set aside for any...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide cytogenetics reagents. The contract has a firm fixed price, purchase order structure, with a potential value of $446,000.00 and a completion date of March 27, 2021. Abbott Molecular is a manufacturer of molecular diagnostic products and services that has previously supported federal agencies like the VA, Centers for Disease Control and Prevention, and Department of the Army with a range of lab equipment, test kits, and support services. The contract does not have a set-aside designation. Abbott Laboratories, as the parent company, has a history of providing medical devices, implants, and testing equipment and services to the VA and Department of Defense under various contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $246.0k | 9/27/20 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 9/14/20 | |
| Not listed | Not listed | $200.0k | 2/28/20 |